Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
6.88
-0.02 (-0.29%)
Dec 5, 2025, 4:00 PM EST - Market closed
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $178.90 million as of December 5, 2025. Its market cap has decreased by -59.89% in one year.
Market Cap
178.90M
Enterprise Value
48.12M
1-Year Change
-59.89%
Ranking
Category
Stock Price
$6.88
Market Cap Chart
Since November 14, 2023, Cartesian Therapeutics's market cap has increased from $166.07M to $178.90M, an increase of 7.73%. That is a compound annual growth rate of 3.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 178.90M | -61.17% |
| Dec 31, 2024 | 460.74M | 330.61% |
| Dec 29, 2023 | 107.00M | -35.57% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 907.27B |
| Johnson & Johnson | 487.57B |
| AbbVie | 403.58B |
| UnitedHealth Group | 301.81B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 252.02B |
| Abbott Laboratories | 217.12B |